8w10e ecis arrays Search Results


90
ibidi GmbH ecis arrays 8w10e
Ecis Arrays 8w10e, supplied by ibidi GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc06591197-59-0-4?v=ibidi+GmbH
Average 90 stars, based on 1 article reviews
ecis arrays 8w10e - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
Applied BioPhysics ecis cultureware electrode arrays 8w10e
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
Ecis Cultureware Electrode Arrays 8w10e, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc05855997-55-4-16?v=Applied+BioPhysics
Average 95 stars, based on 1 article reviews
ecis cultureware electrode arrays 8w10e - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

96
Applied BioPhysics 8w10e arrays
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
8w10e Arrays, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc05579287-273-15-23?v=Applied+BioPhysics
Average 96 stars, based on 1 article reviews
8w10e arrays - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
ibidi GmbH 8-well 8w10e+ ecis arrays
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
8 Well 8w10e+ Ecis Arrays, supplied by ibidi GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pm33720490-260-6-9?v=ibidi+GmbH
Average 90 stars, based on 1 article reviews
8-well 8w10e+ ecis arrays - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

94
Applied BioPhysics electrode arrays 8w10e
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
Electrode Arrays 8w10e, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc07575137-41-9-24?v=Applied+BioPhysics
Average 94 stars, based on 1 article reviews
electrode arrays 8w10e - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Applied BioPhysics ecis zθ instrument
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
Ecis Zθ Instrument, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc03078814-187-21-24?v=Applied+BioPhysics
Average 96 stars, based on 1 article reviews
ecis zθ instrument - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
Lonza egm-1 medium
Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative <t>ECIS</t> tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis
Egm 1 Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/10__1161_slash_atvbaha__109__200949-160-24-26?v=Lonza
Average 90 stars, based on 1 article reviews
egm-1 medium - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

94
Applied BioPhysics 96w10idf
Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on <t>96W10idf</t> ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.
96w10idf, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc05579287-267-14-29?v=Applied+BioPhysics
Average 94 stars, based on 1 article reviews
96w10idf - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Lonza human umbilical vein endothelial cells
Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on <t>96W10idf</t> ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.
Human Umbilical Vein Endothelial Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc03809386-440-0-5?v=Lonza
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Harrick Plasma Inc argon plasma
Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on <t>96W10idf</t> ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.
Argon Plasma, supplied by Harrick Plasma Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/10__1074_slash_jbc__ra118__005685-340-27-36?v=Harrick+Plasma+Inc
Average 90 stars, based on 1 article reviews
argon plasma - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza phenol red free ebm
Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on <t>96W10idf</t> ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.
Phenol Red Free Ebm, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc03809386-440-9-13?v=Lonza
Average 90 stars, based on 1 article reviews
phenol red free ebm - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
Applied BioPhysics 96w20idf type electrode arrays
Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on <t>96W10idf</t> ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.
96w20idf Type Electrode Arrays, supplied by Applied BioPhysics, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8w10e++ecis+arrays/pmc05087712-874-42-13?v=Applied+BioPhysics
Average 95 stars, based on 1 article reviews
96w20idf type electrode arrays - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative ECIS tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis

Journal: Journal of Intensive Care

Article Title: Leukadherin-1 ameliorates endothelial barrier damage mediated by neutrophils from critically ill patients

doi: 10.1186/s40560-018-0289-5

Figure Lengend Snippet: Endothelial barrier disruption by neutrophils isolated from healthy ( n = 14), trauma ( n = 8), and septic donors ( n = 6) and protection by LA-1. Change in normalized resistance with respect to time. T = 0 represents time of neutrophil addition to HUVECs activated by TNF for 4 h. a Representative tracing of electrical resistance across activated HUVEC monolayers in the presence of neutrophils obtained from healthy, trauma, or septic donors. b Values are mean ± SEM of normalized resistance at 60 min following PMN addition. Analyses were performed evaluating the effect of neutrophils obtained from critically ill trauma patients ( n = 8), from critically ill septic patients ( n = 6), and from healthy controls ( n = 14) and assayed in duplicate on each experimental day. c Representative ECIS tracing of neutrophils added to HUVEC monolayer 30 min after fMLP (10 −6 M). d Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. e – g Representative tracings of neutrophils ± fMLP activation in the presence or absence of LA-1. e Neutrophils obtained from healthy donors. f Neutrophils obtained from trauma patients. g Neutrophils obtained from septic patients. h Values are mean ± SEM of normalized resistance at 60 min following PMN addition ± fMLP. * p < 0.05 vs. healthy unstimulated; ** p < 0.05 vs. healthy fMLP-stimulated; # p < 0.05 vs. trauma unstimulated; ## p < 0.05 vs. trauma fMLP-stimulated; @ p < 0.05 vs. septic unstimulated; and @@ p < 0.05 vs. septic fMLP-stimulated. Statistical significance determined ( p < 0.05) using three-way ANOVA with post hoc Tukey analysis

Article Snippet: Electric cell-substrate impedance sensing (ECIS) cultureware electrode arrays (8W10E+) and 16-well array station were obtained from Applied BioPhysics (Troy, NY).

Techniques: Disruption, Isolation, Activation Assay

Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on 96W10idf ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.

Journal: Scientific Reports

Article Title: A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity

doi: 10.1038/s41598-017-10392-0

Figure Lengend Snippet: Functional RhoGTPases siRNA screen identifies new regulators of the endothelial barrier. ( a ) Schematic representation of the siRNA screen. Upper left corner, clockwise: the selected 270 siRNA targets distributed by functional group: RhoGTPases (22), RhoGEFs (82), RhoGAPs (66), RhoGDIs (3), Rho-effector proteins (76) and Rho-associated genes (21). 270 SMARTpools and control siRNAs were forward transfected into primary HUVECs seeded on 96W10idf ECIS arrays (n = 3 independent experiments). Endothelial barrier resistance was measured for 72 h following transfection by ECIS. Typical graph of the ECIS readout is shown. Depicted in green are exemplary readings of genes that enhance barrier function after knock-down; in red, genes that decrease barrier function upon loss-of-function; in black, a control non-targeting siRNA. Statistical analysis was performed and hits were identified as detailed in Results. Validation experiments were performed on the top hits. ( b ) Overview of individual mean endothelial resistance values registered at 72 h post-transfection of each siRNA pool (black dots) (n = 3). The average resistance of the non-targeting siRNA controls is represented by the background blue line. (n = 54). In grey, the threshold value set at ±200 ohm on the average non-targeting siRNA controls. Statistically significant hits, not all of which also induced large deviations in barrier function, are indicated by circles. ( c ) Distribution of 10 top hits by functional group.

Article Snippet: Briefly, passage 2 cells (1 × 10 4 cells/well) were seeded on 1% gelatin-coated 96w10idf or (1 × 10 5 cells/well) 8w10E arrays connected to the ECIS®ZTheta Array Station (Applied Biophysics, Troy, NY) and transfected as described above.

Techniques: Functional Assay, Transfection